This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Complementary and Alternative Medicine  • Treatment Adherence  • Quality of Care, Other  • Adverse Effects  • Alert me on articles by topic  Social Bookmarking   What's this?

Patricia M. L. A. van den Bemt, PhD; Anne J. Leendertse, PharmD; Lennart J. Stoker, PharmD; Antoine C. G. Egberts, PhD

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

We thank Bollu et al for their reaction to our article on the HARM study.¹ They wonder whether we have given consideration to the Beers list in our study. We have used available literature on medication appropriateness for the assessment of the hospital admissions. To determine their preventability, we used pharmacotherapeutic guidelines and specific protocols for elderly patients, including the Beers list. However, we did not look specifically at the medications on the Beers list, but to all medications the patients used in relation to the adverse drug event that caused the hospital admission. Those medications also included OTC and herbal medicines. Although certain nonsteroidal anti-inflammatory drugs are available as OTC medications in the Netherlands, most of the hospital admissions for adverse drug events from antiplatelet and . . . [Full Text of this Article]

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Frequency of and Risk Factors for Preventable Medication-Related Hospital Admissions in the Netherlands
Anne J. Leendertse, Antoine C. G. Egberts, Lennart J. Stoker, Patricia M. L. A. van den Bemt, and for the HARM Study Group
Arch Intern Med. 2008;168(17):1890-1896.
ABSTRACT | FULL TEXT